Skip to main content
logo
K Pharma,Inc. (TYO:4896)
Japan flag Japan · Delayed Price · Currency is JPY
764.00
+4.00 (0.53%)
Aug 27, 2026, 1:16 PM JST

K Pharma,Inc. Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1,000--
Revenue Growth
------
Gross Profit
---910--
Operating Income
-950-916-836367-353-219
Net Income
-1,041-993-846260-392-228
Earnings Per Share
-89.64-85.57-72.9023.07-42.01-30.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,3642,7912,2683,2661,336188
Total Debt
1,6371,500----
Net Cash (Debt)
7271,2912,2683,2661,336188
Net Cash Growth
-60.40%-43.08%-30.56%144.46%610.64%-
Net Cash Per Share
62.60111.25195.44289.79143.1824.73

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,013-918-983454--
Capital Expenditures
-34-11-14-9--
Free Cash Flow
-1,047-929-997445--
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---91.00%--
Operating Margin
---36.70%--
Pretax Margin
---30.00%--
Profit Margin
---26.00%--
FCF Margin
---44.50%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---32.14--
P/FCF Ratio
---18.78--
PS Ratio
---8.36--